PubRank

Yong Bum Yoon

Author PubWeight™ 71.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2008 3.43
2 A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 2006 1.90
3 Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 2008 1.67
4 EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointest Endosc 2007 1.59
5 [Natural history of branch-duct type intraductal papillary mucinous neoplasms of the pancreas]. Korean J Gastroenterol 2007 1.41
6 Does endoscopic sphincterotomy reduce the recurrence rate of cholangitis in patients with cholangitis and suspected of a common bile duct stone not detected by ERCP? Gastrointest Endosc 2007 1.40
7 Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. Clin Gastroenterol Hepatol 2010 1.35
8 Metastasis to the gallbladder: a single-center experience of 20 cases in South Korea. World J Gastroenterol 2009 1.19
9 Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma. Ann Surg Oncol 2007 1.16
10 Risk factors for recurrent cholangitis after initial hepatolithiasis treatment. J Clin Gastroenterol 2004 1.14
11 A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost. Gastrointest Endosc 2009 1.14
12 Survival and prognostic factors of unresectable pancreatic cancer. J Clin Gastroenterol 2008 1.10
13 Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours. Dig Liver Dis 2011 1.10
14 Outcomes of cystic lesions in the pancreas after extended follow-up. Dig Dis Sci 2007 1.09
15 Management strategies for gallbladder polyps: is it possible to predict malignant gallbladder polyps? Gut Liver 2008 1.06
16 Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol 2009 1.06
17 Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas 2008 1.05
18 Endoscopic treatment for biliary stricture after adult living donor liver transplantation. Liver Transpl 2009 1.04
19 Histologic characteristics of gastric polyps in Korea: emphasis on discrepancy between endoscopic forceps biopsy and endoscopic mucosal resection specimen. World J Gastroenterol 2006 1.02
20 Changing patterns of gallstone disease in Korea. World J Surg 2004 1.02
21 Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett 2007 0.99
22 Feasibility of endoscopic papillectomy in early stage ampulla of Vater cancer. J Gastroenterol Hepatol 2008 0.99
23 Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer. Cancer Chemother Pharmacol 2012 0.99
24 Optimal biliary drainage for inoperable Klatskin's tumor based on Bismuth type. World J Gastroenterol 2007 0.98
25 Cyst fluid analysis for the differential diagnosis of pancreatic cysts. Diagn Cytopathol 2004 0.97
26 Cystic neoplasms of the exocrine pancreas: an update of a nationwide survey in Korea. Pancreas 2008 0.96
27 Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms. Ann Surg Oncol 2008 0.95
28 The efficacy of nonsurgical treatment of infected pancreatic necrosis. Pancreas 2007 0.94
29 Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer. Pancreas 2007 0.93
30 Optimal interventional treatment and long-term outcomes for biliary stricture after liver transplantation. Clin Transplant 2008 0.92
31 Secondary appendiceal tumors: a review of 139 cases. Gut Liver 2010 0.92
32 Spontaneous activation of pancreas trypsinogen in heat shock protein 70.1 knock-out mice. Pancreas 2005 0.92
33 Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer. Pancreas 2006 0.91
34 Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis. Gut Liver 2011 0.91
35 Clinical features of chronic pancreatitis in Korea: a multicenter nationwide study. Digestion 2005 0.91
36 Appropriate diagnosis of biliary cystic tumors: comparison with atypical hepatic simple cysts. Eur J Gastroenterol Hepatol 2010 0.91
37 Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas 2008 0.91
38 Proposal of an endoscopic retrograde cholangiopancreatography-related perforation management guideline based on perforation type. J Korean Surg Soc 2012 0.89
39 Clinical features of metastatic tumors of the pancreas in Korea: a single-center study. Gut Liver 2011 0.88
40 A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction. Gastrointest Endosc 2009 0.88
41 Cathepsin B is a target of Hedgehog signaling in pancreatic cancer. Cancer Lett 2008 0.88
42 SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. Cancer Lett 2005 0.87
43 The optimal duration of preoperative biliary drainage for periampullary tumors that cause severe obstructive jaundice. Am J Surg 2013 0.87
44 Clinical outcomes of patients who experienced perforation associated with endoscopic retrograde cholangiopancreatography. Surg Endosc 2012 0.85
45 The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. Pancreas 2012 0.85
46 Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Pancreas 2012 0.85
47 Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 2005 0.85
48 Gastric anisakiasis. Gastrointest Endosc 2004 0.84
49 Clinical usefulness of plasma chromogranin a in pancreatic neuroendocrine neoplasm. J Korean Med Sci 2013 0.84
50 Stent patency using competing risk model in unresectable pancreatic cancers inserted with biliary self-expandable metallic stent. Dig Endosc 2012 0.84
51 Primary pancreatic lymphoma in Korea--a single center experience. J Korean Med Sci 2010 0.83
52 Biliary drainage for obstructive jaundice caused by unresectable hepatocellular carcinoma: the endoscopic versus percutaneous approach. Hepatobiliary Pancreat Dis Int 2012 0.82
53 Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays. Ann Surg Oncol 2012 0.82
54 Risk for post-ERCP pancreatitis after needle knife precut sphincterotomy following repeated cannulation attempts. J Clin Gastroenterol 2007 0.82
55 Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property of gemcitabine in pancreatic cancer. Pancreas 2011 0.81
56 Higher prevalence of obesity in gastric cardia adenocarcinoma compared to gastric non-cardia adenocarcinoma. Dig Dis Sci 2012 0.81
57 Endoscopic management of occluded metal biliary stents: metal versus 10F plastic stents. World J Gastroenterol 2010 0.80
58 Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia. Gut Liver 2012 0.80
59 [Pancreatic endocrine tumors: clinical manifestations and predictive factors associated with survival]. Korean J Gastroenterol 2008 0.80
60 Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic ductal adenocarcinoma: analysis of 1,446 patients from the pancreatic cancer cohort in a single institution. PLoS One 2013 0.80
61 Risk factors of acute cholecystitis after endoscopic common bile duct stone removal. World J Gastroenterol 2006 0.79
62 [Efficacy of percutaneous ethanol injection therapy in Korean with hepatocellular carcinoma]. Korean J Gastroenterol 2003 0.79
63 Results of repeat endoscopic retrograde cholangiopancreatography after initial biliary cannulation failure following needle-knife sphincterotomy. J Gastroenterol Hepatol 2012 0.79
64 Palliative treatment of unresectable hepatocellular carcinoma with obstructive jaundice using biliary drainage with subsequent transarterial chemoembolization. J Palliat Med 2013 0.78
65 Pancreatic pseudocyst after endoscopic ultrasound-guided fine needle aspiration of pancreatic mass. Clin Endosc 2012 0.78
66 [A case of pancreatic somatostatinoma]. Korean J Gastroenterol 2006 0.78
67 A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1. Gut Liver 2013 0.78
68 Endoscopic papillectomy for benign ampullary neoplasms: how can treatment outcome be predicted? Gut Liver 2013 0.78
69 Inflexinol reduces severity of acute pancreatitis by inhibiting nuclear factor-κB activation in cerulein-induced pancreatitis. Pancreas 2013 0.77
70 [Cationic trypsinogen gene mutation in patients with chronic idiopathic pancreatitis]. Korean J Gastroenterol 2004 0.77
71 Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma. Ann Surg Oncol 2014 0.76
72 Clinical factors associated with accuracy of EUS-FNA for pancreatic or peripancreatic solid mass without on-site cytopathologists. J Gastroenterol Hepatol 2014 0.76
73 Presence of coronary artery disease increases the risk of biliary events in patients with asymptomatic gallstones. J Gastroenterol Hepatol 2013 0.76
74 A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer. Gut Liver 2013 0.76
75 Long-term outcome of cystic lesions in the pancreas: a retrospective cohort study. Gut Liver 2012 0.75
76 Roles of endoscopic sphincterotomy and cholecystectomy in acute biliary pancreatitis. Hepatogastroenterology 2009 0.75
77 Adenoma of the duodenal papilla. Gastrointest Endosc 2004 0.75
78 Intraductal papillary mucinous neoplasms of the pancreas with anomalous union of the pancreaticobiliary ducts. Pancreas 2007 0.75
79 Polymorphisms of the MCP-1 and HSP70-2 genes in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 2008 0.75
80 [Mutations of SPINK1 and PRSS1 gene in Korean patients with chronic pancreatitis]. Korean J Gastroenterol 2004 0.75
81 Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis. Pancreas 2008 0.75
82 [Quantification of plasma DNA as a tumor marker in patients with pancreatic cancer]. Korean J Gastroenterol 2005 0.75
83 Submucosal saline-epinephrine injection in colon polypectomy: appropriate indication. Hepatogastroenterology 2008 0.75
84 Long-term clinical outcomes of biliary cast syndrome in liver transplant recipients. Liver Transpl 2013 0.75